# Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administration

> **NCT00793702** · PHASE1 · COMPLETED · sponsor: **Statens Serum Institut** · enrollment: 42 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** rdESAT-6 + rCFP-10

## Key facts

- **NCT ID:** NCT00793702
- **Lead sponsor:** Statens Serum Institut
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2013-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00793702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00793702, "Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administration". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00793702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*